Evidence map›Paper›PMID 40066742›Full record

ArticleMolecular pharmaceutics2025

Ceramide Profiling of Porcine Skin and Systematic Investigation of the Impact of Sorbitan Esters (SEs) on the Barrier Function of the Skin.

Hans Schoenfelder, Moritz Reuter, Dirk-Heinrich Evers, Michael E Herbig, Dominique Jasmin Lunter

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hans SchoenfelderDepartment of Pharmaceutical Technology, Faculty of Science, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, Tuebingen 72076, Germany.ORCID 0009-0004-1547-2665
Moritz ReuterDepartment of Pharmaceutical Technology, Faculty of Science, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, Tuebingen 72076, Germany.ORCID 0009-0009-7085-5462
Dirk-Heinrich EversRaDes GmbH, Schnackenburgallee 114, Hamburg 22525, Germany.
Michael E HerbigRaDes GmbH, Schnackenburgallee 114, Hamburg 22525, Germany.
Dominique Jasmin LunterDepartment of Pharmaceutical Technology, Faculty of Science, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, Tuebingen 72076, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stratum corneum (SC) lipids provide the main barrier of the skin against the environment. Ceramides make up about half of the lipids by weight and are thus of particular interest. Emulsifiers are used in a multitude of topical formulations, e.g., to stabilize emulsions against coalescence. Investigations showed that some emulsifiers have the potential to impair skin barrier function. Sorbitan esters (SEs) are frequently used emulsifiers in pharmaceutical and cosmetic dermal formulations. Further, cholesterol and lecithin were used as natural alternatives. However, information on their impact on ceramides is very scarce. Thus, we first analyzed the SEs by LC-MS with regard to their composition. Then we developed an LC-MS method to identify and quantify the ceramides in porcine skin and subsequently investigated the impact of emulsifiers on the ceramide profile. Besides the LC-MS measurements, the effect of emulsifiers on the skin barrier function was investigated by trans-epidermal water loss (TEWL) measurements and confocal Raman spectroscopy (CRS). Throughout the experiments, water was used as a negative control and sodium lauryl sulfate (SLS) as a positive control. It was found that SEs are mixtures of mono-, di-, and triesters, partially with a complex fatty acid distribution. LC-MS measurements of the total ceramide content of the SC samples revealed the SE 60 and cholesterol-treated samples to be those showing the least ceramide depletion, implying a high skin tolerability in general. The TEWL measurements showed that SEs 40, 60, 80, and 120 showed no significant changes in skin barrier function. The lipid content, measured by CRS, was mostly decreased except for SE 120. Conformation, chain order, and SC thickness, also measured by CRS, showed no significant differences. These detailed investigations lead to the view that SEs are skin-friendly substances and can be used for topical applications, e.g., those commonly used to treat skin diseases.

Indexed as

CeramidesHexosesSkinAnimalsChromatography, LiquidEmulsifying AgentsEpidermisEstersMass SpectrometrySpectrum Analysis, RamanSwineCeramidesEmulsifying AgentsEstersHexosessorbitan monooleateceramidesconfocal Raman spectroscopyemulsifiersin vitrolipidsliquid chromatography−mass spectrometryporcine skinsorbitan esterstratum corneumtrans-epidermal water loss

Identifiers

PMID40066742
PMCPMC11979889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.